Survivors’ Plasma Won’t Help Fight COVID in Patients With Early Symptoms
FRIDAY, Aug. 20, 2021 (HealthDay News) — Early treatment with COVID-19 survivors’ blood plasma doesn’t prevent disease progression in people who have mild COVID-19 symptoms but are at risk for more severe illness, a new clinical trial finds. “As physicians, we wanted this to make a big difference in reducingContinue Reading










